RPRX Stock Analysis: Buy, Sell, or Hold?
RPRX - Royalty Pharma plc Class A Ordinary Shares
$61.31
0.73 (1.21%)
▲
5d:
+4.62%
30d:
+3.88%
90d:
+14.49%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When RPRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RPRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RPRX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$68.42
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$42.48
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RPRX is currently trading at $61.31, which is considered extended relative to its 30-day fair value range of $57.10 to $59.84. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.7) compared to its historical average (9.0). At these levels, the market is pricing in 6.0% annual earnings growth.
Technical Outlook: Technically, RPRX is in a strong uptrend. The price is approaching resistance at $62.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RPRX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RPRX is in a strong uptrend. The price is approaching resistance at $62.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RPRX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$57.10 -
$59.84
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding RPRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($64.75)
- BULLISH: Expecting earnings turnaround to 6.0% growth with 16.5% revenue growth
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$57.10 -
$59.84
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$56.53
Resistance Level
$62.13
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.69
Wall Street Target
$64.75
(+5.6%)
Revenue Growth (YoY)
16.5%
Earnings Growth (YoY)
-46.3%
Profit Margin
32.0%
Valuation Premium vs History
+6.0% premium
PE vs Historical
10.7 vs 9.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.0%
(market-implied from PE analysis)
1-Year Target
$64.99
(+6%)
2-Year Target
$68.89
(+12%)
3-Year Target
$73.02
(+19%)
3-Yr Target (if PE normalizes)
(PE: 11→9)
PE COMPRESSION
$61.49
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 7.6%)
$143.57
(+134%)
Base:
(SPY PE: 10.7, Growth: 7.6%)
$76.45
(+25%)
Bear:
(PE: 9.0, Growth: 7.6%)
$64.38
(+5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 32.57 | Current EPS (TTM): $1.86
Bull Case
$133.28
(+117%)
Analyst growth 100.0%, PE expands to 35.8
Base Case
$121.16
(+98%)
Market implied 100.0%, PE stable at 32.6
Bear Case
$41.19
(-33%)
Severe decline -20.0%, PE contracts to 27.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 5:18 PM ET
Data refreshes hourly during market hours. Next update: 6:18 PM
Data refreshes hourly during market hours. Next update: 6:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Terrance P Coyne
SELL
34791 shares
2026-04-01
Terrance P Coyne
SELL
34791 shares
2026-03-23
Terrance P Coyne
SELL
34791 shares
2026-03-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$39 | 52 HOLD |
Advanced RPRX Option Strategies
Professional options setups generated by AI based on today's RPRX price and gamma walls.
